Dean Klotman and Manesh Patel, MD discuss the transformative role of philanthropy in advancing cardiovascular research and care at Duke. Their conversation highlights how the university's recent MADE FOR THIS fundraising campaign is fueling innovation, collaboration, and purpose-driven support to shape the future of heart health.

A Duke study shows the experimental drug SBI-810 blocks pain at its source—calming nerve signals without the side effects of opioids. In mice, it eased pain from surgery, bone fractures, and nerve injury without causing sedation or constipation.

More than 300 volunteers and friends joined Duke Health leaders, faculty, students, and staff for a special weekend May 1-3 highlighting the critical role of philanthropy in driving  innovation, discovery, and patient care. 

Study led by Duke School of Medicine reveals cancer’s weak spot – a protein that helps cells make energy and stops cancer from growing.

Congratulations to the 442 students from the Duke University School of Medicine who graduated on Sunday, May 11, 2025, marking the successful culmination of their hard work and dedication.

Professor of Medicine Michael Hershfield's research has transformed the lives of patients with rare immunodeficiencies and treatment-resistant gout. Now he's made a philanthropic gift to support early career physician-scientists at Duke.

A new, high-resolution atlas of the mouse brain will increase precision in measuring changes in brain structure and make it easier to share results for scientists working to understand neurological diseases such as Alzheimer's.

A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.